BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20702004)

  • 21. "USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT.
    Cohade C; Mourtzikos KA; Wahl RL
    J Nucl Med; 2003 Aug; 44(8):1267-70. PubMed ID: 12902417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake.
    Kostakoglu L; Hardoff R; Mirtcheva R; Goldsmith SJ
    Radiographics; 2004; 24(5):1411-31. PubMed ID: 15371617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
    Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
    J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of BMIPP-SPECT/CT to
    Frankl JA; An Y; Sherwood A; Hao G; Huang FY; Thapa P; Clegg DJ; Sun X; Scherer PE; Öz OK
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement in sensitivity with delayed imaging of pulmonary lesions with FDG-PET.
    Núñez R; Kalapparambath A; Varela J
    Rev Esp Med Nucl; 2007; 26(4):196-207. PubMed ID: 17662186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of catecholamines on the glucose uptake in brown adipose tissue demonstrated by (18)F-FDG PET/CT in a patient with adrenal pheochromocytoma.
    Yamaga LY; Thom AF; Wagner J; Baroni RH; Hidal JT; Funari MG
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):446-7. PubMed ID: 17909796
    [No Abstract]   [Full Text] [Related]  

  • 28. [
    de Paula Faria D; D'Arc Campeiro J; de Souza Junqueira M; Real CC; Marques FLN; Hayashi MAF; Sapienza MT
    Nucl Med Biol; 2023; 122-123():108362. PubMed ID: 37356164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limitations of dual time point FDG-PET imaging in the evaluation of focal abdominal lesions.
    Döbert N; Hamscho N; Menzel C; Neuss L; Kovács AF; Grünwald F
    Nuklearmedizin; 2004 Oct; 43(5):143-9. PubMed ID: 15480502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions.
    Nakajo M; Jinnouchi S; Fukukura Y; Tanabe H; Tateno R; Nakajo M
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2088-95. PubMed ID: 17713765
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Ricci M; De Feo MS; Granese GM; Frantellizzi V; Carabellese B; Lubrano E; Cimini A
    Expert Rev Med Devices; 2023; 20(12):1143-1156. PubMed ID: 37965719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-Enhanced Ultrasound: A Novel Noninvasive, Nonionizing Method for the Detection of Brown Adipose Tissue in Humans.
    Flynn A; Li Q; Panagia M; Abdelbaky A; MacNabb M; Samir A; Cypess AM; Weyman AE; Tawakol A; Scherrer-Crosbie M
    J Am Soc Echocardiogr; 2015 Oct; 28(10):1247-54. PubMed ID: 26255029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT.
    Bar-Shalom R; Gaitini D; Keidar Z; Israel O
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1105-13. PubMed ID: 15007566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeatability of brown adipose tissue activation measured by [
    de Paula Faria D; da Silva Vera CC; Marques FLN; Sapienza MT
    Nucl Med Biol; 2023; 126-127():108390. PubMed ID: 37804561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypically Intense Pharmacologically Induced Brown Fat Activation on FDG PET/CT.
    Brahmbhatt P; Ataei F; Parent EE; Sharma A
    Clin Nucl Med; 2023 Mar; 48(3):233-236. PubMed ID: 36723882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. F-18 FDG PET/CT in the evaluation of Takayasu arteritis: an experience from the tropics.
    Santhosh S; Mittal BR; Gayana S; Bhattacharya A; Sharma A; Jain S
    J Nucl Cardiol; 2014 Oct; 21(5):993-1000. PubMed ID: 24875577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic values of delayed additional FDG PET/CT scan in the evaluation of cardiac sarcoidosis.
    Manabe O; Takahashi K; Kawakami H; Ohtsuka A; Aikawa T; Maki H; Ibe T; Fujita H; Oyama-Manabe N
    Ann Nucl Med; 2023 Oct; 37(10):535-540. PubMed ID: 37418117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vivo Imaging of Brown Adipose Tissue in Humans: FDG-PET/CT and Beyond.
    Virtanen KA
    Methods Mol Biol; 2022; 2448():283-289. PubMed ID: 35167104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse White Adipose Tissue 18F-FDG Uptake-An Unusual Finding on 18F-FDG PET/CT.
    Bansal H; Ravina M; Nanda S; Lukose TT; Krishna S
    Clin Nucl Med; 2021 Oct; 46(10):e513-e514. PubMed ID: 33867453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies.
    Ben-Haim S; Kupzov E; Tamir A; Frenkel A; Israel O
    J Nucl Cardiol; 2006 Nov; 13(6):791-800. PubMed ID: 17174810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.